HLB Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	520,897	472,158	1,219,355	1,165,599	1,077,864	1,188,951
Market Cap Growth	-34.92%	-61.28%	4.61%	8.14%	-9.34%	-7.14%
Enterprise Value	667,766	602,001	1,270,943	1,260,366	1,030,778	1,020,209
Last Close Price	4275.00	3875.00	10010.00	11155.39	10327.26	11533.40
PE Ratio	-	-	198.66	-	-	-
PS Ratio	11.39	10.32	37.21	11.90	10.82	22.23
PB Ratio	1.75	1.59	3.06	5.04	4.57	4.82
P/TBV Ratio	2.12	1.92	3.45	6.66	7.52	6.48
EV/Sales Ratio	14.60	13.16	38.78	12.86	10.35	19.07
Debt / Equity Ratio	0.54	0.54	0.31	0.72	0.63	0.02
Net Debt / Equity Ratio	0.49	0.49	0.11	0.38	0.07	-0.55
Net Debt / EBITDA Ratio	-9.28	-9.28	-3.14	-4.93	-1.05	8.54
Net Debt / FCF Ratio	-3.02	-3.02	-0.75	-2.86	-0.38	8.20
Asset Turnover	0.09	0.09	0.07	0.24	0.29	0.18
Inventory Turnover	7.21	7.21	6.40	12.26	16.27	30.72
Quick Ratio	0.26	0.26	1.86	0.68	5.50	11.28
Current Ratio	0.38	0.38	2.01	0.73	6.00	11.59
Return on Equity (ROE)	-28.68%	-28.68%	2.13%	-2.53%	-22.52%	-18.45%
Return on Assets (ROA)	-2.58%	-2.58%	-2.60%	-3.82%	-3.65%	-3.83%
Return on Invested Capital (ROIC)	-4.94%	-4.74%	-5.24%	-8.94%	-11.00%	-14.52%
Return on Capital Employed (ROCE)	-5.90%	-5.90%	-4.10%	-8.90%	-5.20%	-7.10%
Earnings Yield	-19.16%	-21.14%	0.50%	-0.51%	-5.04%	-4.13%
FCF Yield	-9.31%	-10.27%	-4.86%	-2.63%	-3.75%	-1.39%
Buyback Yield / Dilution	-9.19%	-9.19%	-9.65%	-0.80%	-1.64%	-0.34%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.